Recent Company News

• 04:20 PM ET May 22, 2026
  

  Centessa Pharmaceuticals announces HSR waiting period expires for acquisition by Eli Lilly - 8-K ($39.75, 0.00)

• 06:24 PM ET May 19, 2026
  

  Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders?

• 02:48 AM ET May 12, 2026
  

  Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders?

• 04:11 PM ET May 05, 2026
  

  Centessa Pharmaceuticals reports Q1 GAAP EPS ($0.52) vs year-ago ($0.20) - 10-Q ($39.67, 0.00)

• 11:45 AM ET Apr 29, 2026
  

  StreetAccount Summary - U.S. Unusual Option Volume: VIX +2.7% to $18.31; S&P 500 (0.1%) to $7,132.93

• 04:33 PM ET Apr 20, 2026
  

  Are CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders?

• 06:46 AM ET Apr 20, 2026
  

  Centessa Pharmaceuticals downgraded to equal weight from overweight at Wells Fargo Securities ($39.66, 0.00)